FDA’s Classification of Cellular Analysis Systems
Discover the critical implications of the FDA’s recent classification of cellular analysis systems for antimicrobial susceptibility testing. This course offers in-depth insights into the criteria, special controls, and benefits that ensure device safety and regulatory compliance.
In this course you will learn the following:
* Understand the classification process and criteria for the cellular analysis system.
* Identify the special controls required for compliance.
* Recognize the benefits of the De Novo classification process in reducing regulatory burdens.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.